High placebo response rates have not only undermined a great deal of clinical trials in the past, however, are a major factor in the failure of the phase 3 trials of the vaccination development process. A high placebo response rate can indicate a lack of statistical significance and essentially lead to making matters worse in developing a successful COVID-19 vaccine.